Literature DB >> 27296059

Principles of genetic variations and molecular diseases: applications in hemophilia A.

N Lannoy1, C Hermans2.   

Abstract

DNA structure alterations are the ultimate source of genetic variations. Without them, evolution would be impossible. While they are essential for DNA diversity, defects in DNA synthesis can lead to numerous genetic diseases. Due to increasingly innovative technologies, our knowledge of the human genome and genetic diseases has grown considerably over the last few years, allowing us to detect another class of variants affecting the chromosomal structure. DNA sequence can be altered in multiple ways: DNA sequence changes by substitution, deletion, or duplication of some nucleotides; chromosomal structure alterations by deletion, duplication, translocation, and inversion, ranging in size from kilobases to mega bases; changes in the cell's genome size. If the alteration is located within a gene and sufficiently deleterious, it can cause genetic disorders. Due to the F8 gene's high rate of new small mutations and its location at the tip of X chromosome, containing high repetitive sequences, a wide variety of genetic variants has been described as the cause of hemophilia A (HA). In addition to the F8 intron 22 repeat inversion, HA can also result from point mutations, other inversions, complex rearrangements, such as duplications or deletions, and transposon insertions causing phenotypes of variable severity characterized by complete or partial deficiency of circulating FVIII. This review aims to present the origins, mechanisms, and consequences of F8 alterations. A sound understanding of the multiple genetic mechanisms responsible for HA is essential to determine the appropriate strategy for molecular diagnosis and detected each type of genetic variant.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CNV; F8 gene mutations; Gene targeting; Hemophilia A; Inversion; Molecular Biology methods; Mutation analysis

Mesh:

Substances:

Year:  2016        PMID: 27296059     DOI: 10.1016/j.critrevonc.2016.04.005

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  6 in total

1.  Genome-Wide Identification of Long Noncoding RNA and Their Potential Interactors in ISWI Mutants.

Authors:  Ludan Zhang; Shuai Zhang; Ruixue Wang; Lin Sun
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

Review 2.  Transposable elements in Drosophila.

Authors:  Tabitha J McCullers; Mindy Steiniger
Journal:  Mob Genet Elements       Date:  2017-04-19

3.  Aberrant X chromosomal rearrangement through multi-step template switching during sister chromatid formation in a patient with severe hemophilia A.

Authors:  Mahiru Tokoro; Shogo Tamura; Nobuaki Suzuki; Misaki Kakihara; Yuna Hattori; Koya Odaira; Sachiko Suzuki; Akira Takagi; Akira Katsumi; Fumihiko Hayakawa; Shuichi Okamoto; Atsuo Suzuki; Takeshi Kanematsu; Tadashi Matsushita; Tetsuhito Kojima
Journal:  Mol Genet Genomic Med       Date:  2020-07-05       Impact factor: 2.183

4.  The Ribosomal Protein RpL22 Interacts In Vitro with 5'-UTR Sequences Found in Some Drosophila melanogaster Transposons.

Authors:  Crescenzio Francesco Minervini; Maria Francesca Berloco; René Massimiliano Marsano; Luigi Viggiano
Journal:  Genes (Basel)       Date:  2022-02-05       Impact factor: 4.096

5.  Correction of a Factor VIII genomic inversion with designer-recombinases.

Authors:  Felix Lansing; Liliya Mukhametzyanova; Teresa Rojo-Romanos; Kentaro Iwasawa; Masaki Kimura; Maciej Paszkowski-Rogacz; Janet Karpinski; Tobias Grass; Jan Sonntag; Paul Martin Schneider; Ceren Günes; Jenna Hoersten; Lukas Theo Schmitt; Natalia Rodriguez-Muela; Ralf Knöfler; Takanori Takebe; Frank Buchholz
Journal:  Nat Commun       Date:  2022-01-20       Impact factor: 14.919

6.  Pairing of single mutations yields obligate Cre-type site-specific recombinases.

Authors:  Jenna Hoersten; Gloria Ruiz-Gómez; Felix Lansing; Teresa Rojo-Romanos; Lukas Theo Schmitt; Jan Sonntag; M Teresa Pisabarro; Frank Buchholz
Journal:  Nucleic Acids Res       Date:  2022-01-25       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.